Overview of parametric survival analysis for health-economic applications. - Wikidata - awgldk - TriplyDB

Overview of parametric survival analysis for health-economic applications.

Overview of parametric survival analysis for health-economic applications.

http://www.wikidata.org/entity/Q38106867

about

A review and comparison of methods for recreating individual patient data from published Kaplan-Meier survival curves for economic evaluations: a simulation study.Cost-effectiveness of first-line treatments for patients with KRAS wild-type metastatic colorectal cancer Model-based cost-effectiveness analyses for the treatment of chronic myeloid leukaemia: a review and summary of challenges.Model-based cost-effectiveness analyses for the treatment of chronic lymphocytic leukaemia: a review of methods to model disease outcomes and estimate utility.A primer on marginal effects--Part I: Theory and formulae.EXPLORING PATENT ACTIVITY AND ITS POTENTIAL ASSOCIATION WITH HEALTHCARE OUTCOMES: A CASE STUDY OF OSTOMY PRODUCTS IN SWEDEN.Long-Term Survival Following Traumatic Brain Injury: A Population-Based Parametric Survival Analysis.Simulation and matching-based approaches for indirect comparison of treatments.Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR).Comment on: "Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal".Survival analysis: Part I - analysis of time-to-event.

P2860

Q30914917-4E14C045-01A3-4D24-9102-93F7B739C3B6 Q33982704-2C89B365-A10B-41C4-B23F-84E32561BDCE Q38218300-514ABE8B-2410-43B4-AA79-95B407DEC337 Q38228728-39D226CF-DB63-4F31-B2AE-45F89FCE2EE7 Q38246139-5AF11A9F-E53B-41CF-9800-1700A9A15C58 Q38706413-0847C050-0B18-428C-83D2-11EB528C4490 Q39778037-B0DEC1AF-BD85-4AED-912A-5D4E7BA1646D Q41185903-C6D5ABEE-EA8C-44FF-9C70-EA28675E1573 Q47123934-0D1DBDE6-EF33-409D-A0DA-AC4349B856CF Q53744564-DA33B0C9-3964-41EB-8817-A8AACEFA8B0A Q55221148-57E8047E-5136-473F-8328-458E4F04BE6A

P2860

Overview of parametric survival analysis for health-economic applications.

http://www.wikidata.org/entity/Q38106867

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Overview of parametric survival analysis for health-economic applications.

@en

type

label

Overview of parametric survival analysis for health-economic applications.

@en

prefLabel

Overview of parametric survival analysis for health-economic applications.

@en

P1433

Q38106867-D9E7C108-9909-4EE9-8168-5C57F517A0DE

P1476

Q38106867-24A15483-5465-4DC6-841D-9CE3B34FCDC3

P2093

Q38106867-44FE80F4-BCB9-4AA4-B29E-71D778BCFA1C

Q38106867-B65207A9-9D09-495F-85B4-B61F89A84F6B

Q38106867-E5CDDE0B-4E6D-4EC9-8E26-37AE5E19650E

Q38106867-E84BFEFE-C517-4652-BCAC-ACB0DBAE741D

P2860

Q38106867-040B6BEA-E471-499D-8CD5-37EAD09FBC30

Q38106867-0F0B700B-84E5-4ECA-98E2-C13CA7AE93E8

Q38106867-132B367D-36E9-459E-B9F1-AE5411304A4C

Q38106867-170BE6CA-95B5-469B-B921-36D7D36E9BBD

Q38106867-313021BB-0E60-4AD8-A60A-B01DAC1B6A8A

Q38106867-534B9E4A-E118-4BE9-B5F8-6A60A277E89E

Q38106867-5D72C660-38C0-4EA7-A217-2C818D759CA8

Q38106867-A347D5F6-CA5B-49A0-8657-13104714CC21

Q38106867-A83B6110-9EF8-431A-8707-0483A7A24CDF

Q38106867-A8B466A8-1B93-43F3-93E3-F30AD9E2385A

P2888

Q38106867-AC0A0436-C124-4E6E-9195-0647338AE960

P304

Q38106867-39D61416-2AE6-46D5-9C4A-27F17AC61BE3

P31

Q38106867-8C4491AB-F29F-461D-BE65-DF934B78B1A9

P356

Q38106867-E3C603B2-399D-457E-B0DA-B9C50BA728DE

P433

Q38106867-01C2FD3A-9648-4D86-8CF6-8B27B139831C

P478

Q38106867-8C3B3593-A70E-4EAC-9CA2-33D62E52E551

P577

Q38106867-ACA21498-003B-4F20-B901-F1CFDDA18989

P698

Q38106867-C150091C-412A-4F5D-8AEA-7F76C9ED3201

P356

S40273-013-0064-3

P1433

PharmacoEconomics

P1476

Overview of parametric survival analysis for health-economic applications.

@en

P2093

Agnes Benedict

http://www.w3.org/2001/XMLSchema#string

K Jack Ishak

http://www.w3.org/2001/XMLSchema#string

Noemi Kreif

http://www.w3.org/2001/XMLSchema#string

Noemi Muszbek

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Sorafenib in advanced hepatocellular carcinoma

Estimating survival for cost-effectiveness analyses: a case study in atherothrombosis

Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.

The model-based cost-effectiveness analysis of 1-year adjuvant trastuzumab treatment: based on 2-year follow-up HERA trial data.

Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation.

Improved curve fits to summary survival data: application to economic evaluation of health technologies.

Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.

Treatment of follicular non-Hodgkin's lymphoma with or without rituximab: cost-effectiveness and value of information based on a 5-year follow-up.

P2888

s40273-013-0064-3

P304

663-675

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40273-013-0064-3

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23673905

http://www.w3.org/2001/XMLSchema#string